Monday, 27 April 2015

The Open Access Interviews: Publisher MDPI

Headquartered in Basel, Switzerland, the Multidisciplinary Digital Publishing Institute, or more usually MDPI, is an open access publisher that has had a challenging few years. It has been charged with excessively spamming researchers in order to maximise APC revenue, it has been accused of publishing pseudoscience, and it has been criticised for publishing papers of very poor quality. This has occasionally led to editorial board resignations e.g. here and here.

The criticism came to a head in February last year, when University of Colorado (Denver) librarian Jeffrey Beall added MDPI to his controversial list of “Potential, possible, or probable predatory scholarly open-access publishers”.

Today I am publishing a Q&A with MDPI. First however, in the way of background, I want to rehearse some key events (in date order). Please scroll down if you want to go direct to the interview.

= Update: Jeffrey Beall removed MDPI from his list on 27th October 2015 =
From left to right: Alistair Freeland, Delia Costache, Dietrich Rordorf, Maria Schalnich, Martyn Rittman, Shu-Kun Lin, Franck Vazquez




A target for criticism, but favoured by some


MDPI AG was spun out of Molecular Diversity Preservation International (MDPI) in 2010 by the owner of both organisations Shu-Kun Lin, along with the then CEO of MDPI Dietrich Rordorf. In the process a number of journals were relocated to MDPI, and since then MDPI’s portfolio of open access journals has grown to 137. Last year MDPI published over 12,000 papers.

MDPI’s difficulties appear to have started in December 2010, when one of its journals — Life — published a paper by Erik Andrulis called Theory of the Origin, Evolution, and Nature of Life. Aiming to present a framework to explain life, the paper was greeted with scepticism and ridicule. The popular science and technology magazines Ars Technica and Popular Science, for instance, characterised the ideas in the paper as “crazy” and “hilarious”.

The publication of the paper led to a member of Life’s editorial board resigning, and Shu-Kin Lin published a response to the criticism. In his response, Shu-Kin Lin conceded that he had taken over responsibility for the review process when the researcher assigned to the task (a Professor Bassez) has pulled out for personal reasons. But he insisted that the paper had been properly peer reviewed, and that it had been revised in response to the reports of two reviewers. His explanation, however, attracted further criticism.

In April 2011 a second controversy erupted when the MDPI journal Nutrients published a paper called The Australian Paradox: A Substantial Decline in Sugars Intake over the Same Timeframe that Overweight and Obesity Have Increased. This too attracted criticism, and an Australian economist created a website in order to launch a campaign to have the paper retracted. (There is also a Wikipedia page on the paper here).

The Australian Paradox paper has not been retracted, but it has twice been corrected by the authors (in 2011 and 2014), and in 2012 the Editor-in-Chief published an editorialabout the paper, along with a responseto the criticism from the authors. In addition, in July 2014 the University of Sydney (the institution where one of the authors is based) published an independent reportconcluding that of the seven criticisms that had been levelled at the authors the “only allegation substantiated concerned two ‘simple arithmetic’ errors, specifically an inconsistency and an incorrect calculation”.

Notwithstanding these controversies, MDPI has attracted many supporters, not least amongst OA advocates and cognoscenti of open access. When, on 31stOctober 2012, MDPI launched a new open access journal called Publications, for instance, it was able to recruit well-regarded scholars who specialise in research on open access to its editorial board. Currently, membership of the board includes Mikael Laakso and Bo-Christer Björk (Björk has also publishedin the journal), and at one time de factoleader of the open access movement Peter Suber also served on the board.

OA advocates have also proved more than willing to publish in the journal. Contributors include Heather Morrison (here and here), Martin Eve (here), John Wilbanks (here), and David Solomon (here). And in 2013 Björn Brembs agreed to edit a special issue for the journal.

Also of note, the Editor-in-Chief of Publications is John Regazzi, a former CEO of Ei Inc. (where he founded the first professional engineering online community — the Engineering Information Village). Regazzi is also a former CEO of Elsevier Inc. (I interviewedhim for Information Today in 1998).

Likewise, a number of open access advocates serve on the editorial board of MDPI’s journal Data, including Peter Murray-Rustand Ross Mounce (although the journal does not appear to have published any papers).

Finally, we could note that at one point Suber was also on the editorial board of Future Internet, an MDPI journal that in January 2010 published an articleby Jeffrey Beall called Metadata for Name Disambiguation and Collocation (a contribution that Beall later said he regretted).

More criticism, followed by a pass


In April 2013, however, another controversy erupted — this time over the MDPI journal Entropy, which published a review paper co-authored by MIT’s Stephanie Seneff arguing that glyphosatemay be the most important factor in the development of obesity, depression, attention deficit hyperactivity disorder, autism, Alzheimer's disease, Parkinson's disease, multiple sclerosis, cancer, and infertility.

The paper, which contained no primary research results, attracted considerable criticism (e.g. here), and was characterisedby the popular science magazine Discover as pseudoscience. Again, the paper has not been retracted. Explaining why, MDPI told me: “We have recently conducted an enquiry into the glyphosate paper, and other papers in the same special issue. We have decided not to retract, in part based on recent findings from the International Agency for Research on Cancer [see hereand here] suggesting that glyphosate is ‘probably carcinogenic to humans’.”

We could note in passing that in total 23 papers have been retractedfrom MDPI journals.

In 2013, however, MDPI also passed an important and significant test. On 4th October Sciencepublished an articleWho’s Afraid of Peer Review? — which reported on an exercise in which fake scientific papers had been sent to 304 fee-charging open access journals. The papers contained obvious scientific flaws and so should all have been rapidly rejected. In fact, 157 of the journals they were submitted to accepted the paper sent to them, with only 98 rejecting it.

One of the journals targeted in this “sting” was MDPI’s Cancers. And to its credit the journal rejected the paper sent to it, saying: “Although your analysis is interesting, your manuscript was not given a high priority rating during the initial screening process.”

And in December 2013 MDPI published a response to the criticism it was continuing to face for publishing what it characterised as “controversial articles”. Since the motivations for this criticism “vary widely and can include political or corporate agendas, and competing economic or intellectual interests”, suggested MDPI, rather than post critical comments on social networks and blogs, those wishing to critique MDPI papers should “prepare a scientifically rigorous Comment and submit it to the Editors of the journal for editorial review”.

But the criticism did not stop. In fact, the situation deteriorated — on February 18th 2014 Beall placed MDPI on his list, alleging (amongst other things) that the publisher was in the habit of adding scholars (including Nobel Prize winners) to its editorial boards without their permission, that it had recruited Peter Suber to the editorial board of Publications in order to forestall criticism from OA advocates, that it was launching a fleet of new journals with one-word titles as part of a strategy of creating broad scope journals that would enable it to boost its APC revenues, and that it was regularly publishing controversial papers in order to attract publicity.

On 24th February 2014 MDPI published a response to Beall’s criticisms, refuting all the allegations and pointing out that Beall is no friend to the open access movement, having the year before mounted a generalised attack on OA in an article published in the tripleC journal called, “The Open-Access Movement is Not Really about Open Access”. 

In his article Beall argued that the movement “is an anti-corporatist movement that wants to deny the freedom of the press to companies it disagrees with … [and has] … fostered the creation of numerous predatory publishers and standalone journals, increasing the amount of research misconduct in scholarly publications and the amount of pseudo-science that is published as if it were authentic science.”

Subsequent to Beall adding MDPI to his list (in June 2014), Suber resigned from the editorial board of Publications. However, he told me, the two events were not connected. “I was overcommitted, I needed to drop commitments, and I was dropping others at the same time,” he emailed me.

Again, it is important to stress that MDPI has a great many supporters. Some researchers report having had a positive experience publishing in its journals — see here, hereand herefor instance. In addition, the publisher says, it has recruited 6,500 board members, is currently experiencing 3.8 million page views per month, and it has published the work of more than 170,000 unique authors.

We should also point out that MDPI is a member of the Open Access Scholarly Publishers Association (OASPA), a member of the Committee on Publication Ethics (COPE), and its journals are listed in the Directory of Open Access Journals (DOAJ). Some of its journals are also indexed by PubMed, the Web of Science and Scopus; and some have Impact Factors.

Concerned at the potential consequences of being placed on Beall’s list, on 25th February 2014, MDPI’s Dietrich Rordorf emailed the Chancellor of Beall’s institution asking him to intervene (presumably to have MDPI removed from the list). Rordorf complained that Beall was publishing false information about MDPI. He also pointed out that 14 members of UC Denver faculty had published papers with MDPI, and 65 had reviewed papers for it. In addition, he added, one also serves on the editorial board of MDPI’s Antibodies journal.

Rordorf’s request appears to have fallen on deaf ears. As MDPI explains below, “We were referred to a legal counsel and informed that the university was unwilling to investigate inclusion in Beall’s list.”

In the event despite being placed on Beall’s list, MDPI has seen the number of researchers based at UC Denver who have published papers with grow to 34.

Another pass


In 2014 MDPI passed another important test. Conscious that MDPI is a member of its organisation, OASPA conducted an enquiry into its activities, examining the review process that the controversial papers published by Life and Nutrients had undergone, and investigating the various allegations raised by Beall. The conclusion: On April 11th 2014 OASPA announcedthat “Based on our findings we feel satisfied that MDPI continue to meet the OASPA Membership Criteria.”

Presumably to help reassure researchers about the rigour of MDPI’s peer review process, on 16th May 2014 the then Editor-in-Chief of Life announced that the journal planned to introduce a form of open peer review.

For all that, Beall has not removed MDPI from his list. When I asked him about this he replied, “I do not believe I was wrong to place them on my list. I do think the firm belongs there.”

Clearly frustrated at Beall’s refusal to remove MDPI from his web site, on 14th November 2014 Shu-Kun Lin sent a personal email to Beall, saying, amongst other things, “If you remove the post and remove MDPI from your black list, I can give you the money and help you to do your critics correctly.”

When I asked Beall how he had understood Shu-Kun Lin’s message he replied, “I interpreted his offer of money as an offer to pay me to remove MDPI from my list.”

Explaining his intention below, however, Shu-Kun Lin says, “This offer was to try to help Mr Beall professionalise his operation. Services such as COPE, OASPA and Retraction Watch have managed to maintain themselves and improve their services through raising additional funds.”

In March this year I had an email forwarded to me in which an unnamed person who said s/he had worked for MDPI as a student made a number of allegations about MDPI. The email also suggested contacting former MDPI managing editor Francisco Teixeira who, the author said, could provide “more crazy stories”.

When I contacted Teixeira he replied, “Let me point out that I parted ways with MDPI some years ago and have not kept in touch or been updated with any of the more recent activities of the publisher. I cannot therefore comment on the current state of the publications. What I can say from the time I worked there is that the company kept a thorough blind peer review for its journals, while still aiming at an expedited publication process (which, of course, was not always possible). Despite having released a ‘fleet’ of journals at the time, there was a selection of prospective editorial board members and only with a minimum numbers of members a journal would be launched. As for publishing fees, they would only be charged in case the paper was accepted for publishing (no processing fees).”

What to make of it?


So what should we make of all this? Personally, I have come to believe that we rarely have sufficient information to make judgements about the quality and probity of any specific publisher, or the rigour of the review process that any particular paper has undergone prior to publication. This is particularly unfortunate given that there appears to have been a breakdown of trust in scholarly publishing, not least due to the growing number of retractions we are witnessing. 

What I would prefer to do, therefore, is to pose a few general questions about the phenomenon of so-called predatory publishing.

1.       As commentators like John Dupuis have pointed out, predation is by no means confined to open access publishers. Most notoriously, in 2009 it was reported that the leading subscription publisher, Elsevier, had been publishing fake journals. These were sponsored by unnamed pharmaceutical companies and made to look like peer reviewed medical journals. Might it not be better to talk about “predatory behaviour” rather than predatory publishers or predatory journals, and should we not be scrutinising the activities of all scholarly journals, not just open access journals?

2.       We have got used to talking about predatory publishers. But what about predatory researchers? And what about the predatory environment in which researchers now have to operate? Clearly, some publishers are guilty of unethical business practices, but fundamentally all they are doing is meeting a market demand. In apportioning blame when things go wrong, therefore, should we not be asking to what extent responsibility ought to be laid at the feet of the research community, and its dysfunctional scholarly communication system, as much as at the feet of publishers? Is not the appalling pressure to publish (both quickly and frequently) that researchers face today an important contributory factor to the growing number of scandals and retractions? In other words, should not as much (if not more) blame and opprobrium be levelled at the causes of the predatory behaviour we see today as on the publishers who profit from this dysfunctional system?

3.       Leaving aside those instances where publishers do blatantly unethical things — like failing to send a paper out for review, ignoring the reviews, or creating fake journals (offences that may in fact be less frequent than we tend to assume) — is it not the case that ultimate responsibility for the publication of erroneous, shoddy, fraudulent and/or fake research belongs to the researchers who produce such papers, and the researchers who fail to review them properly, not to the publisher? After all, publishers are rarely able to judge the value of a piece of research themselves. That is why they ask third-party researchers to make the judgement for them?

4.       In light of the current lack of information available to enable us to adequately judge the activities of scholarly publishers, or to evaluate the rigour of the publication process that research papers undergo, should not both scholarly publishers and the research community be committing themselves to much greater transparency than we see today? For instance, should not open peer review now be the norm? Should not the reviews and the names of reviewers be routinely published alongside papers? Should not the eligibility criteria and application procedures for obtaining APC waivers be routinely published on a journal’s web site, along with regularly updated data on how many waivers are being granted? Should not publishers be willing to declare the nature and extent of the unsolicited email campaigns they engage in in order to recruit submissions? Should not the full details of “big deals” and hybrid OA “offsetting agreements” be made publicly available? Should not publishers be more transparent about why they charge what they charge for APCs? Should not publishers be more transparent about their revenues and profits? For instance, should not privately owned publishers make their accounts available online (even where there is no legal obligation to do so), and should not public companies provide more detailed information about the money they earn from publicly-funded research and exactly how it was earned? And should not publishers whose revenue comes primarily from the public purse be entirely open about who owns the company, and where it is based? Should not the research community refuse to deal with publishers unwilling to do all the above? Did not US Justice Louis D. Brandeishave a point when he said, “Sunlight is said to be the best of disinfectants; electric light the most efficient policeman.”

These are just a few questions. There are many more that could be asked.

In the meantime, I invite people to read the Q&A below. When I proposed the interview I invited MDPI founder Shu-Kun Lin and MDPI Chief Production Officer Martyn Rittman to do it jointly. During the process, however, they chose to assign many of the answers to MDPI as an entity, rather than to themselves. In that same spirit, they have provided a group photo to go with the interview.

The interview begins


RP:  Can you both say who you are and what your role at MDPI is, plus provide some brief details about your respective backgrounds and careers prior to MDPI?

S-K L: I am founder and Publisher of MDPI. I was born in Hanchuan, Hubei Province, China and graduated with a BSc from Wuhan University in January 1982, majoring in inorganic chemistry. I studied physical chemistry in the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986, MSc in 1985) and in the USA (University of Louisville, 1987–1989).

I received my doctorate (organic chemistry) at the Swiss Federal Institute of Technology (Swiss Institute of Technology, ETH, Zurich) in 1992 after studying for three years in the group of Prof. Dr. Bernhard Jaun, Laboratory of Organic Chemistry.

In 1996, I initiated a samples collection and exchange project, and founded the international organization MDPI in Switzerland to implement this. In the same year I launched the first MDPI journal Molecules. In 2001 I became a professor at the Ocean University of China (OUC).

I am the founder or co-founder of several other open-access journals: Entropy (1999), International Journal of Molecular Sciences (2000), Sensors (2001), Marine Drugs (2003) and the International Journal of Environmental Research and Public Health (2004).

I became the Editor-in-Chief of Molecular Diversity(Springer) in 2002 and held this position until my resignation in June 2007. I am the principal author of over 40 publications.

MR: I am Chief Production Officer at MDPI. I graduated in mathematics and physics from the University of Warwick in 2004, before completing an MSc and PhD under Warwick’s interdisciplinary MOAC program. My final project focused on spectroscopy of DNA and modelling biopolymerization processes.

I went on to a three year postdoc at the University of Reading, using atomic force microscopy and small angle X-ray scattering to analyze nano-structured biomaterials. I followed this with a further postdoctoral position at the University of Freiburg, developing TIRF microscopy of protein complexes. I joined MDPI in April 2013.

Further information about MDPI personnel can be found here.

RP:  When and why was MDPI founded?

S-K L: I initially started MDPI as a project to preserve rare chemical samples, having seen a number of valuable samples simply disposed of. This project is still running. The first journal, Molecules, was started in 1996 to publish the synthesis of samples submitted to the collection. From the beginning, articles have been available for free online.

RP:  Where is the company based and who owns it?

S-K L: MDPI is owned by me and has been based in Basel, Switzerland since the outset. Since 2008 we have established three offices in China, two in Beijing and one in Wuhan. However the headquarters of the company remains in Basel and the management, online publication, marketing and training activities are organized from this office.

RP: As I understand it there are two separate organisations: the MDPI Sustainability Foundation (previously Molecular Diversity Preservation International, which was founded by you and Benoit R Turin in 1996), and MDPI AG, an open access publisher that was spun out of the above organisation by you and Dietrich Rordorf in 2010. Is that correct, and are you saying that you are the sole owner of MDPI AG (i.e. you own 100% of the company and there are no other investors)?

S-K L: That is correct, and currently I am the sole owner of the publishing house.

RP: Can you say how many employees MDPI has, how many are based in each of the four offices, and where you personally are based? Also, what specific activities take place in the three Chinese offices?

S-K L: I have lived in Switzerland since 1989 and am currently based in Basel, although there are frequent visits from staff based in Basel to China and vice-versa. There are about 30 employees in the Basel office, and 65 in each of the two offices in Beijing and 90 in the office in Wuhan.

We also employ freelance English editors based in various locations. Editorial work and some management tasks take place in all offices. Our in-house production team doing file conversion (Word or LaTex to XML and to PDF, HTML) is based in the Chinese offices. The IT team is split between Basel and one of the Beijing offices.

Money and management


RP: What is MDPI’s current turnover and profit level? And is any financial information about the company publicly available?

MDPI: The average invoice amount for article processing charges in 2014 was approximately 1,250 CHF and we published over 12,000 papers. About 25% of the papers were published free of charge, mostly in journals that were launched over the past few years but also many invited papers in established journals. We have no other significant revenue streams (e.g. advertising), apart from a modest income from ordered reprints.

RP: Presumably you earn revenue from the circa 60 institutions that have joined the MDPI membership scheme, and perhaps you earn some income from the Sciforum.net site?

S-K L: At present there is no revenue from either of these two. However we may introduce a yearly fee for membership in the future. We also have plans to earn revenue from some aspects of Sciforum.net, although many services, such as MDPI conferences and discussion groups, will remain free for users.

RP: My understanding is that researchers based in institutions that have joined the MDPI membership scheme get a discount when they publish with MDPI. If that is right, what is the discount, and can you say what value the scheme has offered MDPI to date if it has not been earning any revenue from it?

MDPI: The discount available for authors at member institutions is displayed on the institutional membership website here, and is typically 10%. We have seen an increase in submissions from member institutions and it has helped us to work more closely with librarians.

Member institutions can access our submission system to track papers submitted by their staff and APCs, and receive automated alerts for new submissions. Our aim for the membership scheme is not primarily monetary, but to build more direct links with authors and their institutions.

MDPI is expanding and re-investing a large part of the income (what would otherwise be profits). Nonetheless, the company is debt free and our earnings have allowed us to expand comfortably, while improving and enlarging our services over the years.

So, for instance, we are currently investing in other services like Sciforum.net, which is a registration and abstract processing platform for scholarly societies to handle their conferences. Societies that self-manage their conferences can use it for free.

In 2014 we created a free platform that offers statistics about scholarly publishers and their journals, mostly based on data from CrossRef. Such initiatives take time and have a cost attached, but we want to offer them for free to the community to help support scholarly communication and build transparency.

RP: What is this free platform you mention?

MDP: The site is currently in beta form, but can be viewed here. We expect it to be fully functional later this year.

RP: Your point about reinvestment is well taken, but presumably MDPI has audited accounts. So can I ask again: Can you share with me MDPI’s current turnover and its profit (or loss) figure? And can you say whether these figures are publicly available? Are they, for instance, available via a Swiss Companies House? Do you publish them yourself on the Web?

S-K L: MDPI is a privately owned Swiss company and as such has no obligations to publish accounts. We don’t currently publish this information, however we reiterate that we are financially sustainable. The revenue in 2014 was around 12 million CHF.

RP: What other business interests do you have, and has any money been used from these to support MDPI, or money from MDPI used to support these other businesses?

S-K L: MDPI neither supports nor is supported by any external businesses or investors.

RP: Can I ask about management. I believe that Dietrich Rordorf has had two periods as CEO of MDPI AG, and is currently CTO, having been replaced by Delia Costache last year. Was this because Dietrich’s background is corporate finance rather than publishing, whereas Delia worked as a Journal Publishing Manager at scholarly publisher Wiley? Or was there some other reason?

S-K L: Delia Costache has a great deal of experience in scholarly publishing and she has been the Journal Development Manager of MDPI since she joined in 2013. Since February 2015 she has been the CEO, replacing me who took over from Dietrich Rordorf ad interim in 2014.

RP: Why did Dietrich Rordorf cease to be CEO in 2014?

S-K L: This was so that Dietrich could concentrate more time on management of some of the new IT projects, such as Sciforum.net and the publisher statistics site mentioned above. That is where he now focuses the majority of his attention.

RP:  How many journals does MDPI currently publish, are they all open access journals, and are they all electronic only?

MDPI: We currently publish 137 journals — see here for details. All of these are open access and in an online-only format.

RP: You said that MDPI charges approximately 1,250 CHF for publishing a paper. The cost is not the same for all MDPI journals then? Also are there any page charges?

MDPI: We do not apply the same APC to all journals. Established journals with an impact factor have higher APCs than the younger ones. There are no page charges. Specific information about APCs is available here. Applications for waivers or discounts are treated on a case by case basis.

RP: What criteria does MDPI apply when considering a waiver, and what do researchers need to do to demonstrate that a waiver is appropriate in their case?

MDPI: We have an exception process to provide discounts or waivers in cases where authors are no longer able to cover the full Article Processing Charges. Such applications are rare and decisions are made based on the specific details of each case. We also provide waivers and discounts as a service to external editors and publish selected waived papers invited by editors.

Peer review and marketing


RP: What kind of peer review system does MDPI operate — e.g. traditional peer review (blind/double blind etc.), or is some form of open peer review used?

MDPI: All journals offer traditional single blind peer review: the reviewer names are anonymous, and at least two review reports are obtained from at least two reviewers.

Life offers an option for open peer review, by which we mean that authors have the option for review reports to be published with the final manuscript and reviewers can optionally sign the published reports. We plan to expand this to other journals in 2015 and implement a double-blind peer review process for Business and Economics titles.

RP: What exactly is the process that papers go through when they are submitted, and who makes what decision?

MDPI: Managing editors receive submitted manuscripts and perform a basic check, desk rejecting obviously poor manuscripts after consultation with the academic editors (Editor-in-chief, Guest Editor, or an Editorial Board member). The Academic Editor may advise on the selection of reviewers at this stage.

Papers are peer reviewed by at least two independent scholars, with multiple rounds of review where necessary. The final decision to publish is always made by an Academic Editor with no conflict of interest.

RP:  Do the journals apply traditional criteria when reviewing papers, or do they use a PLOS ONE-style model (no subjective evaluation of a paper’s likely impact or importance, but papers must be judged to be “technically sound”)?

MDPI: Published papers must be technically sound and provide novelty. In most cases we don’t attempt to judge the impact. However, academic editors are empowered to filter as they wish.

RP: What is the average rejection rate of papers submitted to MDPI journals?

MDPI: The overall rejection rate has increased slightly in recent years from around 50% to a value of 52% in 2014. In 2015 it lies at 54% so far.

RP: How many papers have been retracted from MDPI journals, and what is the most common reason for retracting a paper?

MDPI: You can see all 23 retractions from MDPI here. Reasons for retraction vary, and include duplicate publication, plagiarism, fake data, authorship and funding issues, and misrepresented or misinterpreted experiments.

MDPI is a member of the Committee on Publication Ethics (COPE) and follows its guidelines where ethical issues are raised in relation to articles.

RP: Does MDPI seek submissions to its journals by means of unsolicited email messages? If so, how does it target the researchers it approaches, how many messages does it send out a week, and if the recipients do not wish to receive future email invitations what can they do to stop receiving them?

MDPI: We contact selected researchers to invite them to contribute articles to our journals. In almost all cases this is in relation to a special issue, and invitations are coordinated with the Guest Editor. We also enforce strict limits on the number of messages that can be sent and how often individuals are contacted.

We ensure that messages are directed to researchers who match the scope of the invitation and do not, for example, purchase lists of contacts from third parties. We are very aware that misdirected emails are not welcome, however many scholars welcome notifications about opportunities to publish within their field.

Our procedures strictly follow Swiss regulations, including clearly visible information about the pricing of offered services, an option to opt out of future similar messages, and protection of the data of recipients.

MDPI is not alone in sending out announcements of publishing opportunities. We know from academic editors who work with us that other leading publishing companies also send call for papers e-mails for their journals.

RP: Can you clarify what you mean when you say that strict limits on the number of messages that can be sent are enforced, and can you say approximately how many unsolicited email invitations are sent out in a typical week?

MDPI: All such messages are sent out after checking against a central database. This enables us to closely control recipients, for example by performing final checks on the suitability of recipients, check the size of mailings, control frequency of contact, and enforce opt-out requests. A large fraction of recipients are authors, reviewers, editors, or readers, who are already familiar with MDPI journals.

Jeffrey Beall and other critics

RP: As you will know, US librarian Jeffrey Beall runs a controversial web site in which he lists what he calls “Potential, possible, or probable predatory scholarly open-access publishers”. In February 2014, Beall added MDPI. He has also written about MDPI on a number of other occasions alleging, amongst other things, that the publisher spams researchers, that it lists prominent researchers on its editorial boards without their agreement, and that it has published junk science. I know that MDPI has responded to these allegations, and I know that the Open Access Scholarly Publishers Association (OASPA) — of which MDPI is a member — has investigated Beall’s claims and given MDPI a clean bill of health. I also know that MDPI has responded separately to the concerns that Beall and others (e.g. here, here, and here) have raised over the quality of some of the papers it has published. I contacted Beall recently to ask if he now believes he was mistaken to include MDPI on his site. He replied, “I do not believe I was wrong to place them on my list”. Certainly, he has not removed MDPI from it. For the record, do you categorically deny all the allegations that Beall has made against MDPI, and do you reject the suggestion that there is anything predatory about MDPI and/or its business practices?

MDPI: Of course, we deny all of the accusations made by Jeffrey Beall. He has never made any attempt to contact us to corroborate his claims. We have provided him with sufficient evidence to counter the allegations he made, but he has chosen to ignore this information. 

There are many aspects that can be easily checked by looking at the information on our website. For other allegations, we can provide evidence upon request, and have done so to Jeffrey Beall, OASPA, and several other parties who have enquired about these issues.

RP: At one time the prominent open access advocate Peter Suber was on the editorial board of one of MDPI’s journals — a point made by Beall when he added MDPI to his list. As I understand it, Suber is no longer associated with MDPI in any way. Why is that?

MDPI: Peter Suber has served on the Editorial boards of Future Internet (the same MDPI journal that Jeffrey Beall formerly published a paper in), and subsequently the journal Publications. He wrote to us in June 2014 that he no longer has time to serve on the editorial board due to other commitments. He has never had any other formal connection to MDPI, but provided support and advice immediately after Jeffrey Beall added MDPI to his list, for which we are grateful.

RP: Do you believe that there are predatory open access publishers operating today? If so, how significant a problem do you believe they pose for the research community, and what can/should the community be doing to address the problem?

MDPI: The term “predatory” is pejorative and implies a business is exploiting its customers, for example by leveraging market position to set prices which — under normal market conditions — could not be realised, engaging in anti-competitive practices, or charging without providing a service. We are aware of some questionable practices by small entities that have tried to use the open access model to make money while providing little or no service.

Unfortunately, some of these practices have had a detrimental effect on the reputation of open access in general, but we believe that authors nowadays are more vigilant. Organisations such as OASPA, DOAJ and COPE, and the numerous indexing services (for example, the Science Citation Index Expanded [Web of Science], PubMed, Scopus, Compendex etc.) are helpful in identifying reputable publishers that meet standards and adhere to ethical practices.

Whitelists are more useful to authors than blacklists, and the quality of a publisher’s practices will show in the published content.

RP: Is MDPI’s continued inclusion on Beall’s list harming its business in any way?

MDPI: As mentioned above, the majority of scholars are capable of making up their own mind based on the high standards of our editorial practices, membership of relevant organizations, and indexing in the most relevant databases (75 % of our content is indexed in Web of Science, for example).

Few scholars mention Beall’s list to us, but when provided with information from our website and OASPA they usually decide to publish with us. Our authors, reviewers and Academic Editors know our practices very well, and they are the most appropriate references for our quality.

The overall effect is difficult to tell, but we have seen continued steady growth in terms of the number of papers published. However, the posting of incorrect information on the internet has certainly not been a benefit.

RP: What can publishers do if they feel that they have been inappropriately added to a black list like the one run by Beall?

MDPI: Jeffrey Beall runs an appeal service, which we requested. However the results were rather confusing. The reviews, supposedly from independent experts, clearly showed that they had not received any of the information we passed to Mr Beall, nor had the time to perform a thorough review.

The reviews included comments like “The instructions to authors is minimal”, “sites also lack instructions for referees, which lead me to question whether or not they have any” (This information is easy to obtain and we could have provided on request). Other comments included, “I can ‘smell’ some corruption” (with no justification for this remark), and “Please accept my apology for delay and not able [sic] to submit a proper report”.

We are aware of a number of people who have spoken to Mr Beall to request MDPI’s removal, but he has chosen to ignore them.

It is up to the publishing community as a whole to evaluate the methods of Jeffrey Beall and others like him, and decide whether they are capable of running such a service. Given Beall’s well-known opposition to open access and his reluctance to run his list in cooperation with others or contact the organisations he criticises, we suggest that he is biased and his methods of assessment are flawed.

RP: I believe that in February 2014, Dietrich Rordorf emailed the Chancellor of the University of Colorado Denver (where Beall is employed) asking him to intervene and have MDPI’s name removed from Beall’s list. Did he get a sympathetic hearing? Did anything get resolved as a result of Rordorf’s email?

MDPI: We were referred to a legal counsel and informed that the university was unwilling to investigate inclusion in Beall’s list.

RP: Subsequently you personally emailed Beall (last November, around eight months after OASPA had given MDPI a clean bill of health) to ask him to remove MDPI from his list. In that email you wrote, “If you remove the post and remove MDPI from your black list, I can give you the money and help you to do your critics correctly.” Did you receive a response to this email? What did you mean when you said you could give Beall money? And how much money did you have in mind?

S-K L: This offer was to try to help Mr Beall professionalise his operation. Services such as COPE, OASPA and Retraction Watch have managed to maintain themselves and improve their services through raising additional funds.

Mr Beall did not respond to our proposal. Instead, we have undertaken projects such as the publisher statistics website to provide scholars with accurate information about publishers.

RP: MDPI has also been targeted by critics in China, or at least you personally have — most notably by someone called Dr. Xin Ge. I am confused as to what this is all about: can you say briefly what allegations have been made, and why you think you have been targeted?

S-K L: Dr Xin Ge, a former scientist, has been targeting a number of people associated with a well-known Chinese scientist Dr Shi-Min Fang, the inaugural winner of the John Maddox Prize for “standing up for science”. Dr Ge has written over 20 open letters to Nature, none of which have been published. In a letter about me and MDPI, he made many ridiculous and false allegations.

It appears, however, that Jeffrey Beall may have read the allegations and been influenced by them. MDPI’s relation to Dr Fang is through sponsorship of the “Scientific Spirit Prize”, run in China by Dr Fang.

RP: In one of his posts Beall says,“When publishers like MDPI disseminate research by science activists like Stephanie Seneff and her co-authors, I think it’s fair to question the credibility of all the research that MDPI publishes. Will MDPI publish anything for money?” We can assume the answer to this question is no, if only because MDPI did not fall for the John Bohannon sting, the details of which were published in Science in 2013. However, some believe that the article-processing charge is an inherently problematic business model since, they say, it puts OA publishers under considerable pressure to publish as many papers as possible. This, they add, will inevitably lower the quality of published research. Would you agree that APCs are problematic, and do you envisage MDPI eventually moving away from the APC in favour of a different kind off business model?

MDPI: All papers published by MDPI have been through peer-review by at least two experts. The final decision to accept a paper is made by an external academic with no conflict of interest – including financial interest – regarding publication: almost all our academic editors work on a voluntary basis and none are full-time employees or operate on a commission. This is the most important step in our editorial procedure to ensure that the decisions to publish are unrelated to financial considerations.

Of course, every publishing model may have its weaknesses, for example subscription models are biased against negative results, and typically earn at least five times the income per paper that a gold open access journal does; journals which rely on prestige have been known to publish flawed papers (see, for instance, the paperon arsenic-based lifeforms published in Science in 2011 or those published in Nature concerning methods of stem cell production (hereand here).

The current trend for ‘big deals’ for journal subscriptions has led to just a few very large publishers controlling a large amount of academic publishing and less competition. We constantly review our procedures to see where we can improve, and fully investigate any cases of questionable publication reported to us. However, we are satisfied that our processes are robust, and many active scholars around the globe are willing to publish with MDPI.

We do not have plans to move away from the APC model. However we will monitor any emerging models and respond as necessary.

RP: I am wondering whether it would be easier for researchers to establish who was predatory and who was legitimate if OA publishers were more transparent about their activities and their finances. I am also thinking that greater transparency might prevent legitimate publishers from being accused of being predatory. For instance, I realise that private companies are not obliged by law to publish their accounts, but might it not help if OA publishers did make them public? In addition, some argue that the concept of open access implies more than simply making research freely available, that it also places OA publishers under an obligation to be more transparent and open about their activities than traditional scholarly publishers. Indeed, even publishing consultant Joseph Esposito has called for greater transparency. As he put it, “Let’s be open about open access”. Are you sympathetic to such suggestions? If not, what are your reservations?

MDPI: We think that open access publishers are more transparent about their revenues compared to subscription-based publishers. OA publishers display their charges on the website and one can easily calculate a rough estimate of the income by counting the number of papers.

In the case of subscription based journals, you know the price per subscription, but the number of subscriptions per journal is usually confidential, as well as other sources of income at journal level (advertising, reprints, copyright, etc.). Of course, they publish an annual report, but these are general figures for the company overall, or per division.

RP: Finally, can you say what plans you have for MDPI in the future, and what your goals are for the company in the next few years?

S-K L:  We aim to continue supporting scholars in communicating and disseminating their research by expanding all of MDPI’s ongoing projects.

RP: Thank you very much for taking time to answer my questions.

Wednesday, 15 April 2015

Co-publishing with Against the Grain

I recently agreed to co-publish four interviews with the ATG NewsChannel. The first of the Q&As is with librarian Marcus Banks, and can be read on the Against the Grain website here(or in the post below).

Marcus is a former editor-in-chief of the open access journal Biomedical Digital Libraries, a journal that had to cease operations in 2008.

Amongst other things, Marcus discusses the lessons he learned from his experience with Biomedical Digital Libraries, the economics of OA publishing, and the possibility of journals evolving into blogs.

Against the Grain publishes news about libraries, publishers, book jobbers, and subscription agents. Its goal is to link publishers, vendors, and librarians by reporting on the issues, literature, and people that impact the world of books and journals.  

Tuesday, 31 March 2015

The Life and Death of an Open Access Journal: Q&A with Librarian Marcus Banks

Librarians have been at the forefront of the open access movement since the beginning, not least because in 1998 the Association of Research Libraries (ARL) founded the Scholarly Publishing and Academic Resources Coalition (SPARC). Today SPARC is arguably the world’s most active and influential OA advocacy organisation.
Marcus Banks
It is important to note that librarians’ interest in open access grew primarily out of their frustration with the so-called “serials crisis” — the phenomenon that has seen the cost of scholarly journals consistently grow at a higher rate than library serials budgets.

SPARC’s initial strategy, therefore, was to encourage the growth of new low-cost, non-profit, subscription journals able to compete with the increasingly expensive ones produced by profit-hungry commercial publishers. As SPARC’s then Enterprise Director Rick Johnson wrote in 2000, “In 1998, after years of mounting frustration with high and fast-rising commercial journal prices, a group of libraries formally launched SPARC to promote competition in the scholarly publishing marketplace. The idea was to use libraries’ buying power to nurture the creation of high-quality, low-priced publication outlets for peer-reviewed scientific, technical, and medical research.”

In the wake of the 2002 Budapest Open Access Initiative (an event attended by Johnson), however, SPARC began to focus more and more of its efforts on open access. The assumption was that this would not only allow research to be made freely available, but finally resolve the affordability problem faced by the research community. As the BOAI text expressed it, “the overall costs of providing open access to this literature are far lower than the costs of traditional forms of dissemination.”

Ironically, despite their high profile advocacy for open access many librarians have proved strangely reluctant to practice what they preach, and as late as last year calls were still being made for the profession to start “walking the talk”.  

On the other hand, many librarians have embraced OA, particularly medical librarians. In 2001, for instance, the Journal of the Medical Library Association (JMLA) began to make its content freely available on the Internet. And in 2003 Charles Greenberg, then at the Yale University Medical Library, launched an open access journal with BioMed Central called Biomedical Digital Libraries (BDL). One of the first to join the editorial board (and later to take over as Editor-in-Chief) was Marcus Banks, who was then working at the US National Library of Medicine.

Four years later, however, BDL became a victim of BMC’s decision to increase the cost of the article-processing charges (APCs) it levies. This meant that few librarians were able to afford to publish in the journal any longer, and submissions began to dry up. Despite several attempts to move BDL to a different publishing platform, in 2008 Banks had to make the hard decision to cease publishing the journal.

What do we learn from BDL’sshort life? In advocating for pay-to-publish gold OA did open access advocates underestimate how much it costs to publish a journal? Or have publishers simply been able to capture open access and use it to further ramp up what many believe to be their excessive profits? Why has JMLA continued to prosper under open access while BDL has withered and died? Was BDL unable to compete with JMLA on a level playing field? Could the demise of BDL have been avoided?  What, if anything, does the journal’s fate tell us about the future of open access?

I discuss these and other questions with Banks below. The issue of affordability, it seems to me, is particularly apposite, as librarians are having to confront the harsh truth that, far from reducing the costs of scholarly communication, open access appears more likely to increasethem.

It turns out that Banks has an interesting perspective on this issue. As he puts it, “At the risk of frustrating many librarian colleagues, I must say that the framing of open access as a means of saving money has been and remains a serious strategic error.”

He adds, “A fully open access world may not save any money and could cost more than we pay now — this world would include publication charges as well as payments for tools that mined and sorted the now completely open literature. That’s fine with me, because in this world we’d be getting better value for money.”

The interview begins …


RP: Can you say something about your background and career to date?

MB: I have been a librarian since 2002. My first position after earning my Masters of Library and Information Science was as an Associate Fellow at the US National Library of Medicine (NLM), from 2002-2004. During this time NLM was developing PubMed Central (PMC) as a freely accessible digital archive of biomedical literature.

Growth at PMC was slow, as deposits to it were voluntary — this was years before PMC became the required repository under the terms of the NIH Public Access Policy. Publishers rightly worried that a fully open access archive would challenge their business model, a concern that persists today.

Watching this debate unfold raised my awareness of the various agendas in scholarly publishing, as well as of the potential for open access publishing to expand the reach of biomedical literature.

RP: What are you doing currently?

MB: My most recent position was as the Director of Library/Academic & Instructional Innovation at Samuel Merritt Universityin Oakland, California. Since then my wife and I have returned to the Chicago area for both personal and professional reasons. I am currently pursuing employment while building a consulting practice devoted to transformation in scholarly communication. Even with “gainful employment” I would continue the consulting.

RP: You said that the growing debate about scholarly communication made you aware of the potential for open access publishing. You were later involved in the creation of an open access journal called Biomedical Digital Libraries, which I think was launched in 2004 but ceased operations in 2007. Can you say what your role at the journal was, why the journal was created, and why it did not succeed?

MB: Charles Greenberg, then at the medical library of Yale, launched Biomedical Digital Libraries (BDL) at the Medical Library Association meeting in May 2003. It was an open access title published by BioMed Central (BMC). His first task was to recruit an editorial board, and I joined in as an Associate Editor. Our first papers appeared in 2004. As Charlie moved on to other projects, I became co-editor and then sole Editor-in-Chief in 2006.

Charlie really believed that librarians, as vocal proponents of open access, should practice what they preach by launching a digital open access journal. At this time our association publication, the Journal of the Medical Library Association(JMLA), was becoming open access and thus was also "walking the walk." But JMLA kept a print production schedule even though articles also appeared online (this is not the case anymore, there are early release online articles).

We offered rapid peer review and publication as soon as the article was ready. We also had a larger core author base than JMLA — data mining papers from computer scientists would have been very welcome in BDL. That said, the majority of our authors came from academic libraries.

BMC published BDLfor 4 years. During the beginning of that tenure many academic institutions provided generous memberships that fully, or mostly, covered the author's cost of publication in BMC titles. Librarians do not generally have large research budgets that can cover OA publishing fees, so this was vital to our primary author base. (JMLA publication was then, and is still, free of cost to authors.) BMC’s institutional membership costs were affordable, and predictable, in those first years. The costs were flat each year, and easy to budget.

Then BMC went to a scaled model, in which the cost of an institutional membership would rise in proportion to how many BMC publications from a given institution appeared each year. (This has likely changed significantly by now, this was the situation in 2006-2007). The more you publish, the more you pay, and there was no way in advance to know what the final bill would be.

This caused library directors, who generally paid for the BMC memberships, to cancel them in large numbers. Once those memberships went away so too did publication subsidies. Our primary author base, which was not in a position to pay more than $1,000 per paper to publish, dried up. The journal stopped publication on BMC as of the end of 2007. 

Although in some respects this is a “failure,” we did some interesting things. Along the way we went to open rather than anonymous peer review, which is still a fairly novel approach. We also published papers about “altmetrics” years before that term existed. It was a good run.

RP: I know that in 2007 a number of institutions cancelled their BMC membership, including Yale, citing “skyrocketing” increases. Do you think perhaps when they began to advocate for pay-to-publish gold OA open access advocates underestimated the cost of publishing a journal, or are those who argue that publishers overcharge nearer the mark?

MB: I’d have to side with the argument that publishers overcharge, including open access publishers. The PeerJ innovation shows that smaller charges can sustain a quality journal, and most of the journals listed in the DOAJ have no publication charges and yet they exist.

The fact that traditional publishers absorbed OA titles into their portfolios — like Springer with BioMed Central in 2008 — shows that there is a profit margin in OA. This is not completely bad; the world needs commerce, and at least the profitable OA titles are available to all online readers while the profitable subscription titles are restricted. But I’m not convinced that the author fees charged by some OA publishers reflect the actual costs of publication.

What do we learn?


RP: To what extent do you feel that BDL’s fate was a consequence of the field in which it published — librarianship?

MB: Not much. Many librarians have tenure obligations and are required to publish. JMLA continues to thrive, as do other library journals. In a way BDL was an outlier publication in BMC, a library-focused journal on a platform that generally published hard science.

RP: After it ceased operating as a BioMed Central journal you tried to transfer BDL to an Open Journal Systems platform, and then to the University of California’s eScholarship platform. Why did neither of these attempts succeed either?

MB: These attempts occurred in 2008. Their main advantage was no author fees for publication. But by this time I had maintained my own blog for three years, almost as long as my time with BDL. I was finding blogging to be a more effective means of sharing insights and research about librarianship, which at the time sported a vibrant "biblioblogosphere." So I argued that library journals should evolve into blogs, something that is still possible today although the credentialing power of formal publication cannot be discounted.

Given my circa-2008 feelings about the potential of blogs I became disinterested in propping up the journal model. Meanwhile, our editorial board members had moved on to other projects.

RP: Where do you stand today on the issue of whether journals should be replaced by blogs?

MB: Conceptually I still believe that a well-managed community blog could serve the same function as a journal, and disseminate new insights more quickly than a journal. Culturally, though, there is still tremendous branding and credentialing power from getting a paper in the “right” journal.

Given this I see blogs as complementary or additive to journals for academic publishing, at least at the present time. That said, in some cases blog posts will also be part of the scholarly record. OCLC has done great work recently on preparing a Framework for the Evolving Scholarly Record, which makes this same point about how new content types are now part of the record.

RP: Your vison of journals evolving into blogs is subject-specific right? It wouldn’t be realistic to publish, say, general medical papers on blogs?

MB: Indeed, receptivity to non-standard scholarly items such as blog posts is subject-specific. General medical journals are likely to assume, and value, their established forms for years to come. I must note, though, that one of the principal justifications for this established form is because of the ostensible power of peer review to sort the wheat from the chaff. This is despite evidence that pre-publication peer review can be too cautious and slow.

As Kahneman and Tversky demonstrated, we are more afraid of losing what we know (in this case, peer review) than we are excited about embracing what we do not yet understand (in this case, different ways to do science).

RP: How did you plan to cover the costs of publishing BDL on OJS?

MB: We were hosted by Scholarly Exchange, which initially offered hosting free for a year (as I recall) and then with affordable rates after that. Within that first year I made the switch to the University of California eScholarshipplatform, which was permanently free as long as it had sponsorship by a University of California entity (which we had from UC San Francisco.)

It appears that Scholarly Exchange is still operating, although their web site has not been updated for a few years.

RP: What do we learn from the failure of BDL to prosper in terms both of open access and of scholarly communication more generally?

MB: Although leading OA titles like those from BMC or PLOS charge author fees, many of the titles that appear in the Directory of Open Access journals do not, as I noted earlier. I also pointed out that there are now new funding models, such as PeerJ’s lifetime memberships.

So the question of financing for open access titles — and what exactly this financing supports (is it the actual publication? or the shareholders of companies with OA in their portfolios?) — is an unsettled area that will probably always be vexed. At least the traditional subscription model, for all of its shortcomings, is able to sustain an enterprise.

That said, the PeerJ innovation shows there is enough energy behind OA to be entrepreneurial. And I feel that within the next decade or two immediate OA to biomedical content, with no publication embargos, will be required by law. If this is true the funding streams to support such a law will materialise.

Costs


RP: Based on your experience then, how much would you say its costs to publish an open access journal?

MB: I’ll need to dodge this question somewhat, as my experience as the editor at BDL was removed from the balance sheets available to BMC. All I knew was that I had a set number of author fee waivers I could grant each year, which I generally used for authors from less-wealthy nations. I relied on the balance of authors to come from institutions that mostly (or ideally, completely) subsidised publication.

Beyond my experience, the reported figures for publishing articles open access vary widely. Outsell’s average cost for a publishing an OA article in 2011 was $660, but during that same year Nature reported that it would cost $30,000-$40,000 per paper to go completely OA. This figure beggars belief, no matter how selective a journal may be.

Less insidious are claims from many publishers that it is hard to isolate the mean cost of publishing an open access paper, as these costs are absorbed within complex business entities and/or cross-sudsidised by other parts of a publishing enterprise (as at PLOS, where PLOS One papers underwrite papers in other journals.)

But even this explanation is unsatisfactory. My view aligns with Andrew Odlyzko’s, which is that article publication costs of $400/article should be sufficient. Any figure appreciably higher than that is likely a reflection of a publication’s perceived non-substitutability in the market, and not the actual costs of publication.

RP: I assume Nature’s figures are based not on how much it costs to publish a journal, but on what Nature estimates it would need to charge in order to maintain its current revenues if it migrated to an OA model. In 2004 Richard Charkin, then CEO of Macmillan, put it this way to British MPs: “in order to replace [Nature’s] revenues you would have to charge the author somewhere between £10,000 and £30,000 because the costs of editorial design and support are so high.” Be that as it may, you said that most of the journals in the DOAJ have no publication charges. I wonder how indicative that is of how OA publishing is likely to develop in the future. First, to get an accurate picture one would presumably need to count the number of papers published that require payment of an APC, not the number of journals? Second, do you not think that we will see the traditional commercial publishers take control of the OA publishing market — that is certainly how I interpret the recent blog post by the Wellcome Trust’s Robert Kiley. (See Table 3 in particular) What is your view?

MB: Charkin’s quote assumes that all of the incumbent practices from the print-based publishing model must be maintained in their entirety, and in perpetuity, even in a digital-only publishing environment. The Odlyzko paper I cited above proposes many ways that digital publishing can be made more cost-effective and efficient.

As to Kiley’s post I read it somewhat differently — his main critique is with the practices of hybrid journals, which charge much higher average APCs than fully open access journals. That conclusion reinforces the similar finding of Solomon and Bjork in their Wellcome study one year ago. I think that, if every journal were fully open access, APCs would be lower on average and thus funder dollars would stretch further.

But maybe that is a distinction without much consequence, as your main point is that commercial publishers are likely to exploit the move to open access as a vibrant profit center. I agree, and in principle this does not concern me. At least in this universe publisher profits would support immediately available OA literature, rather than the two-tiered, embargoed system we have now.

That said, in my perfect universe the prices publishers charged to produce open access articles would be regulated just like electricity or water rates. In the main bioscience publishers are offering research that derives from government or non-profit funds that are meant to improve public health, which would be the legal basis for such a regulatory scheme.

Of course such a prospect is very dim, given the political climate against government regulation that is particularly virulent in the US right now. And even in a pro-regulatory environment publishers would point to their multinational character as proof of being impossible to corral since capital knows no borders.

Short of regulation, funder pressure to drive down the cost of APCs (perhaps via APCs caps at hybrid journals, as Kiley references in his post) may work. And if that does work, regulation won’t be needed.

RP: What do you think the implications would be if the transition to open access saw no reduction in the overall cost of scholarly communication? I know you have argued that open access is not about solving the serials crisis, but if we are to believe librarians scholarly communication is in the grip of a serious, and long-standing, affordability problem. If open access cannot offer cost savings then presumably that problem could only intensify in an OA environment surely?

MB: At the risk of frustrating many librarian colleagues, I must say that the framing of open access as a means of saving money has been and remains a serious strategic error.

As Stewart Brand said, information wants to be free and expensive at the same time. Publishing only on the free side of the equation has enabled librarians to be painted as free-loaders who don’t wish to pay for valuable products. It has also spawned publisher propaganda that the role of librarians should simply be to increase their budget bids so that everything can continue as normal.

A fully open access world may not save any money and could cost more than we pay now—this world would include publication charges as well as payments for tools that mined and sorted the now completely open literature. That’s fine with me, because in this world we’d be getting better value for money.

Sense of injustice?


RP: Just to confirm: JMLA is now an open access journal? I could not find a web page for the journal?

MB: JMLA is currently open access. The web site is here.

RP: The site you point to is a section of PubMed Central. So the journal doesn’t actually have its own site; it is publishing directly on PubMed Central. This, as you may know, has attracted criticism, notably from Kent Anderson on The Scholarly Kitchen. Anderson makes a number of points, but for our purposes let’s just consider his claim that this has allowed the MLA to save “between $200,000 and $500,000 (or more) in hosting costs” over a ten-year period. If he is right, it suggests to me that BDL was at a significant disadvantage from the start. After all, if its primary competitor had to pay no hosting costs then it was not really a level playing field for BDLwas it? Or would you question Anderson’s claim?

MB: Speaking as an author with several publications in JMLA, I see the merit in Anderson’s claim that JMLAhas unequal access to PMC servers vis-à-vis the access provided to other publishers. I’ll have to trust Anderson’s figures regarding the saved hosting costs, as he is a publisher and I am not.

That said, though, Anderson’s claim of JMLA “freeloading” can also be applied to subscription publishers who benefit extensively from the access-control mechanisms set up by universities. As the library director at Samuel Merritt University (SMU) I coordinated closely with my colleagues in Information Technology to ensure that only SMU affiliates had access to our licensed content.

We proactively alerted alumni that they could not access this content, because our licenses did not permit it. If any holes opened up within our walled resources, we closed them. This was all at our and IT’s expense; it is not as though publishers paid SMU for a “licensed content control specialist.”

In his piece Anderson goes to great lengths to detail an analogy about getting into a concert even though you have not paid for a ticket — something that may not cause identifiable harm, but is still unfair. At the outer limit of the analogy, a police officer is granting him the free ticket and then driving him to the concert too. What a sweet deal.

Alluding to JMLA, Anderson says, “Everyone else has to pay for these things, but I don’t. I’m literally getting a free ride.” Publishers enjoy such a free ride every day, in the form of uncompensated labour at universities to preserve subscription-based access arrangements.

RP: Actually I was more interested in your perspective as the former Editor-in-Chief of a journal that was not able to compete with JMLA. Assuming Anderson’s claims are correct, do you not feel a sense of injustice over the favoured treatment afforded JMLA? Might BDL have managed to survive if it had also been able to use PubMed Central as its publishing platform?

MB: Yes, if BDL had been on PMC it may have lasted longer and possibly still exist today. But it also could have lasted longer if we had attracted a wider author base of data scientists etc. I feel no sense of injustice. BDL was an experiment at the dawn of widespread open access publishing, and we learned some useful lessons from it.

As some commenters noted in response to Anderson’s post, the NLM has long had a unique relationship with MLA. To me this explains JMLA’s arrival on PMC; there was no smoking-gun plot of the kind Anderson conjures. He is on stronger ground with his criticisms of PMC’s more recent arrangement with eLife. However, by now PMC is the archive of record for the NIH Public Access Policy.

If NLM/PMC are tipping the scales in favour of open access they are on solid policy ground to do so. I’ve long marvelled at the fact that anything written by a government employee in the scope of their employment is public domain (with the exception of classified material, of course). But anything written by a government independent contractor — which is effectively what an NIH grantee is — can be privatised.

RP: From what you said earlier, I assume JMLA does not charge an APC. How then does it fund its operations?

MB: JMLA does not charge an APC. Any costs of its production are paid from Medical Library Association funds, which are principally derived from member dues and annual conference revenues.

RP: When I contacted Charles Greenberg about BDL he stressed that he did not have an opinion about JMLA and why it went open access, but he gave much the same reasons as you for the failure of BDL. He then said, “I think it would not surprise anyone that grants that cover open access APC charges do not go to librarians, though librarians are partners on more grants, such as CTSA grants that did not exist at the time of BDL's demise.” We could note that librarians are not the only group in academia who are discovering that grants to cover open access APC charges are not going to go to them. Do you think we could we see a growing number of researchers unable to publish their papers as a result? That is what this blog post by professor of behavioural and evolutionary ecology at UCLA Peter Nonacs would seem to portend?
                
MB: Nonacs’s post points to the structural deficiency of the author pays publishing model. As he notes, in the open access environment he now finds himself in the “new poor” along with (among others) librarians who wish to publish.

The only systemic solution is a dedicated funding stream for publishing charges that comes from an institution or funder’s research budget; in proportion to the overall budgets that fund research open access publishing charges are small.

This is much easier said than done given the realities of institutional budgeting practices. Nonetheless there is enough money overall to support immediate, non-embargoed open access — certainly so in the biosciences.

Licensing


RP: I believe BDL published its papers under a CC BY licence. As you will know, licensing has become a contentious issue in the OA movement. Is it the CC BY licence you favour for scholarly research? If so, why? If not, why not?

MB: My preference would be for authors to choose the license that applies to their papers rather than adopt a blanket license adopted by their publishers. Publishers, and librarians, are effectively agents of authors. The intellectual determination regarding under what conditions work can be re-used should rest with those who created it.

RP: Many argue that only scholarly content that has been released under a CC BY licence can claim to be open access. You do not agree?

MB: I do not agree. My view aligns with that of Peter Suber in his Very Brief Introduction to Open Access: “Open-access (OA) literature is digital, online, free of charge, and free of most copyright and licensing restrictions.”

RP: I note that, while JMLAindicates that the copyright in the papers it publishes belongs to the authors, it does not specify a licence. Indeed the PDF files appear to have no copyright notice at all (e.g. here). That would seem to imply “all rights reserved” would it not? Or at least anyone wanting to republish or reuse them in any way would have to assume that wouldn’t they?

MB: That’s a reasonable assumption, but not true in JMLA’s case. The license is effectively CC-BY-NC, as shown here in the author copyright form. The crucial clause:  “Copyright in all articles appearing in the Journal of the Medical Library Associationis owned by their authors. Readers may copy articles without permission of the copyright owners, as long as the author and the Medical Library Association are acknowledged in the copy and the copy is used for educational, not-for-profit purposes.”

RP: I wonder if it is reasonable to expect that anyone wanting to republish, reuse, or perhaps text mine, open access papers should have to hunt down an author copyright form (or contact individual authors) in order to establish whether they can do what they want to do with a paper. I think JMLA is not the only OA journal to be vague or unforthcoming about licensing. Should not all OA journals be totally transparent about what can and cannot be done with the papers they publish? That, after all, was partly the reason for developing the Creative Commons licences.

MB: I agree with you completely. This information should be more concisely and consistently displayed on all open access articles.

Lacunae?


RP: Some commentators have suggested that as open access publishers experiment with new business models a number of them will inevitably fail. This, they say, could see parts of the scholarly record disappear — which is what Jeffrey Beall argues has already happened with some of the journals published by VictorQuest Publications. (The same concern was raised here). In the case of BDL, back copies have been archived on the BMC site, and I think they are also available in PMC. But do you think we could see a spate of open access journals fail, and that this could see lacunae in the scholarly record? Or is the danger no greater than with traditional subscription journals in your view?

MB: I am wary of Jeffrey Beall’s critiques. His useful service of identifying predatory publishers is now marred by his categorical and strident rejection of the value of all open access publishing, even the non-predatory sort. Of course he can espouse this view, but his manner of doing so generates more heat than light.

That said, there is a genuine concern that open access publications with short digital shelf lives could be lost to history (as happened with BDL, the one and only article we published on Scholarly Exchange is now lost to time. You are correct that all the BMC articles are in PMC.)

There is probably a greater risk of this happening with open access titles than with subscription-based publications, which generally have longer track records and/or are managed by profitable companies with a business interest in maintaining this record. This is not an intrinsic fault of open access as a concept though, but rather a reflection of the inherent risks of attempting to challenge and change the long-established business model for scholarly publishing.

RP: OA is a hotly contested topic. In a recent blog post you argued that both publishers and open access advocates distort the truth when making their respective cases. As you put it, “Open access advocates elide the filtering and credentialing role of publication in particular journals, which saves researchers very valuable time in deciding what to read. Subscription-based publishers obfuscate the fact that the marginal cost of posting an article is zero, in order to perpetuate a scarcity-based economy that was necessary for printed materials but is now antiquated.” You also point out that this jostling and obfuscation has now been going on for 15 years without common ground being reached by the two warring factions. How do you see this playing out? Do you, for instance, believe that open access is — as Stevan Harnad put it 18 years ago, “The Inevitable and the Optimal”? If so, how will it eventually be achieved and how much longer will it take?

MB: I agree with Harnad that OA is inevitable, as funder mandates will continue to reduce and eventually eliminate embargoes. This may take a decade, maybe two — hopefully less than either. I have no crystal ball but that writing is on the wall.
That said, I do not believe that OA to the scholarly literature is optimal. It’s just a start. Allow me to quote from that same Medium piece if I may:

“Open access advocates are right that information wants to be free, and publishers are right that information wants to be valuable. That value manifests when information becomes insight. This is value worth paying for. This is how publishers could thrive even in a completely open access world.

“In such a world scholarly papers would be considered a natural resource, like the air. Nobody can meter access to the air, but anyone can build an airplane to glide through it and build a business from there. Let’s glide along ourselves, and move from scarcity-based to insight-based economics for scholarly publishing.”

RP: Thank you for answering my questions. And good luck for the future.

Thursday, 26 March 2015

UCL Vice-Provost comments on the Independent Review of the Implementation of the RCUK Open Access policy

Guest Post by Professor David Price, Vice-Provost (Research), University College London

David Price
Research Councils UK (RCUK) has today released the Report of an independent review body on the implementation of its Open Access policy.

It is not a review of Open Access policies and their implementation in the UK. The Report is quite clear about this – it is a review of the impacts of the implementation of the RCUK Policy on Open Access for its funded research outputs. This is a review which is being undertaken at an early stage in the history of that OA policy. As such, there is much that is good and helpful about the Report’s findings and I will touch on some of these points below.

Overall, however, the Report is a missed opportunity to look at the deeper implications of the move to Open Access in the UK. There are broader issues, in many of which RCUK is a leader, which would have benefited from a more confident treatment by the panel. There is still a great deal of work to do!

The Report looks in some detail at the question of embargoes. While the short embargoes of 6 and 12 months have been taken up by the research community, there is still unhappiness. As the Report says, some of this is due to poor communication of the policy and resulting confusion in the academic community. Another aspect of it, however, is a genuine concern among some communities, for example History scholars, that short embargo periods are harmful to academic freedom to choose where to publish. RCUK needs to look at the issue of embargo periods again.

The Report also highlights a number of problems with the RCUK recommendation of a CC-BY licence for research outputs. If this is the RCUK position, then compliance with the policy would require academics to use this licence. In its review of policy implementation, the Report shows that this has not always been the case. The Report also, quite rightly, highlights the unhappiness of the Arts and Humanities community in the requirement for a CC-BY licence. From the evidence presented, it looks as though this community feels they are being made to dance to a biomedical and scientific tune, where CC-BY is more acceptable. The Report is right to highlight the need for further investigation.

The Report has further nuggets of wisdom. It highlights the administrative costs for universities of implementing the RCUK Open Access policy, building on the London Higher Report supported by SPARC Europe. It also suggests that university and publisher systems should be developed to accommodate ORCID  (for author IDs) and FundRef (for funder information), which will help monitor implementation of the policy in future years.

Table 7 presents some really interesting data on the mean costs of Article Processing Charges (APCs).


OA journals published by non-subscription publishers

Full OA journals published by subscription publishers

Hybrid journals published by subscription publishers

5-year mean (2010-14)
£1,136
£1,164
£1,849

Why are the costs in the final column for Hybrids so much bigger than the rest? It was beyond the remit of the review to investigate this in detail, but this question does need further study. RCUK derives its money from public funds and this is a question which the taxpayer would certainly have a right to understand in more detail.

While the Report contains much that is useful and thought-provoking, there are some big gaps that it should have covered. The Report consciously limits itself to the implementation of the RCUK policy, and does not look at the wider UK Open Access scene in detail. This is a mistake because the RCUK position would be more intelligible if such a wider comparison had taken place. The Report says that the RCUK policy position is broadly complementary to other UK OA policies. Any misunderstandings on this front may be due, it says, to poor communication of the policies. Really? Are there many universities who believe this? The new HEFCE policy for REF 2020 seems to me to be quite different from the RCUK policy, and it is the REF policy that is capturing university attention at the moment. It is only the REF policy which is insisting on ‘deposit on acceptance’. And it is the RCUK policy which encourages Gold OA publications and requires the use of a CC-BY licence. The REF policy is neutral, for example, as to the colour (Gold or Green) of the OA output. To say that the RCUK and REF policies are complementary defies logic. The RCUK Review panel needs to think this one through again.

The Report highlights the shortcomings of universities in gathering data for the review. It is right to do so. There needs to be more accurate reporting next time. In that respect, I would have expected the Review panel to draw up a template for reporting, addressing the issues it identified as weaknesses in the first set of reports. The Report recommends that a template be constructed, but why (when this is such an important issue) did it not draw up this template itself? Not good practice.

Finally, the Report cautiously advocates that RCUK look at the level of funding it gives to fund OA dissemination in future years. A welcome recommendation, but rather weak. Wellcome funds all OA outputs that emanate from its funded research. Why did the RCUK review not make a similar recommendation? As things stand, once RCUK funds are exhausted, universities either have to find monies for APCs themselves or advise the authors to publish their outputs as Green outputs. This is unsatisfactory and will lead to a fragmented publication framework for RCUK research which is in no-one’s interests.

To conclude: the independent Review panel which has produced the review of the implementation of the RCUK Open Access policy has only half done its job. It has produced a detailed analysis about implementation, which is useful. But, in walking away from broader policy issues, it leaves many questions unanswered which should have been tackled. Will future reviews take these issues forward? They should.